Broadwood Partners Condemns Alcon's Fallacious Attacks on STAAR Surgical and Its Prospects Life Science Investing
CMS Establishes Coding Validating Sensus SRT for Treating Non-Melanoma Skin Cancer Life Science Investing
Data Presented at the 2025 Southern Region Burn Conference Reinforce RECELL® System as a Standard of Care in Acute Wound Treatment Medical Device Investing
Yunqi Capital Issues Letter to STAAR Surgical Board Calling for Termination of the Proposed Merger with Alcon Life Science Investing
Vicarious Surgical to Report Third Quarter 2025 Financial Results on November 13, 2025 Medical Device Investing
